# A Study to Evaluate the Antiviral Activity and Immune Response of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)

> **NCT06993480** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Ausper Biopharma Co., Ltd.** · enrollment: 20 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** AHB-137

## Key facts

- **NCT ID:** NCT06993480
- **Lead sponsor:** Ausper Biopharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-07-15
- **Primary completion:** 2026-07-17
- **Final completion:** 2027-02-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06993480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06993480, "A Study to Evaluate the Antiviral Activity and Immune Response of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06993480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*